Print Page | Contact Us | Sign In | Join
Health Care Luncheon/CLE: Integrating Experimental Cell and Tissue Products into Clinical Care
Register View Registrations Map this EventMap this Event Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 10/18/2017
When: 10/18/2017
12 - 1 PM
Where: Map this event »
Chester H. Ferguson Law Center
1610 N Tampa St
Tampa, Florida  33602
United States


Online registration is available until: 10/16/2017
« Go to Upcoming Event List  

1.0 CLE Credit including 1.0 Ethics (applied for)

The goal of this seminar will be to provide an ethical overview of emerging cellular and tissue technology, pertinent FDA regulations and guidance for integrating novel product development into clinical practice, and articulate considerations for ensuring provider and physician compliance.

Topics:

• Examples of emerging cellular and tissue technology
• FDA Regulations and Guidance on cellular, gene, and tissue products that are more than “minimally manipulated”
• Applications

Speaker:

Katherine Drabiak is an Assistant Professor in the College of Public Health at USF HEALTH where she teaches and researches in the area of health law. Drabiak has authored numerous law review articles and her scholarship has appeared in a variety of other journals including the American Journal of Bioethics and the Journal of Law, Medicine, and Ethics. She has experience in both research ethics and clinical ethics to develop guidance policies and best practices for unsettled questions in law, medicine, and ethics. She is an active member of Florida Hospital’s Medical Ethics Committee, and her consultation experience includes contributing to Indiana Biobank, collaborating with the Indiana State Department of Health Newborn Screening Program, and working with the Indiana State Medical Association. She is particularly interested in how emerging medical research and technology shapes the practice of medicine and developing standards for adapting legal and ethical best practices